Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

UHRF2 mRNA Expression is Low in Malignant Glioma but Silencing Inhibits the Growth of U251 Glioma Cells in vitro

  • Wu, Ting-Feng (Neurosurgery and Brain & Nerve Research Laboratory, the First Affiliated Hospital of Soochow University) ;
  • Zhang, Wei (Department of Neurosurgery, The First People's Hospital of Wujiang) ;
  • Su, Zuo-Peng (Neurosurgery and Brain & Nerve Research Laboratory, the First Affiliated Hospital of Soochow University) ;
  • Chen, San-Song (Neurosurgery and Brain & Nerve Research Laboratory, the First Affiliated Hospital of Soochow University) ;
  • Chen, Gui-Lin (Neurosurgery and Brain & Nerve Research Laboratory, the First Affiliated Hospital of Soochow University) ;
  • Wei, Yong-Xin (Neurosurgery and Brain & Nerve Research Laboratory, the First Affiliated Hospital of Soochow University) ;
  • Sun, Ting (Neurosurgery and Brain & Nerve Research Laboratory, the First Affiliated Hospital of Soochow University) ;
  • Xie, Xue-Shun (Neurosurgery and Brain & Nerve Research Laboratory, the First Affiliated Hospital of Soochow University) ;
  • Li, Bin (Neurosurgery and Brain & Nerve Research Laboratory, the First Affiliated Hospital of Soochow University) ;
  • Zhou, You-Xin (Neurosurgery and Brain & Nerve Research Laboratory, the First Affiliated Hospital of Soochow University) ;
  • Du, Zi-Wei (Neurosurgery and Brain & Nerve Research Laboratory, the First Affiliated Hospital of Soochow University)
  • Published : 2012.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

UHRF2 is a member of the ubiquitin plant homeo domain RING finger family, which has been proven to be frequently up-regulated in colorectal cancer cells and play a role as an oncogene in breast cancer cells. However, the role of UHRF2 in glioma cells remains unclear. In this study, we performed real-time quantitative PCR on 32 pathologically confirmed glioma samples (grade I, 4 cases; grade II, 11 cases; grade III, 10 cases; and grade IV, 7 cases; according to the 2007 WHO classification system) and four glioma cell lines (A172, U251, U373, and U87). The expression of UHRF2 mRNA was significantly lower in the grade III and grade IV groups compared with the noncancerous brain tissue group, whereas its expression was high in A172, U251, and U373 glioma cell lines. An in vitro assay was performed to investigate the functions of UHRF2. Using a lentivirus-based RNA interference (RNAi) approach, we down-regulated UHRF2 expression in the U251 glioma cell line. This down-regulation led to the inhibition of cell proliferation, an increase in cell apoptosis, and a change of cell cycle distribution, in which S stage cells decreased and G2/M stage cells increased. Our results suggest that UHRF2 may be closely related to tumorigenesis and the development of gliomas.

Keywords

References

  1. Bronner C, Achour M, Arima Y, et al (2007). The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future? Pharmacol Ther, 115, 419-34. https://doi.org/10.1016/j.pharmthera.2007.06.003
  2. Fournier A, Sasai N, Nakao M, et al (2011). The role of methylbinding proteins in chromatin organization and epigenome maintenance. Brief Funct Genomics, 11, 251-64,
  3. Gibney ER, Nolan CM (2010) Epigenetics and gene expression. Heredity (Edinb), 105, 4-13. https://doi.org/10.1038/hdy.2010.54
  4. Gilbertson RJ, Rich JN (2007). Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer, 7, 733-36. https://doi.org/10.1038/nrc2246
  5. Glaab E, Baudot A, Krasnogor N, et al (2010). Extending pathways and processes using molecular interaction networks to analyse cancer genome data. BMC Bioinformatics, 11, 597. https://doi.org/10.1186/1471-2105-11-597
  6. Hanahan D, Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell, 144, 646-74. https://doi.org/10.1016/j.cell.2011.02.013
  7. He X, Duan C, Chen J, et al (2009). Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. FEBS Lett, 583, 3501-7. https://doi.org/10.1016/j.febslet.2009.10.007
  8. Iwata A, Nagashima Y, Matsumoto L, et al (2009). Intranuclear degradation of polyglutamine aggregates by the ubiquitin-proteasome system. J Biol Chem, 284, 9796-803. https://doi.org/10.1074/jbc.M809739200
  9. Jansen M, Yip S, Louis DN (2010). Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers. Lancet Neurol, 9, 717-26. https://doi.org/10.1016/S1474-4422(10)70105-8
  10. Johnson LM, Bostick M, Zhang X, et al (2007). The SRA methyl-cytosine-binding domain links DNA and histone methylation. Curr Biol, 17, 379-84. https://doi.org/10.1016/j.cub.2007.01.009
  11. Just WW (2012). FOCUS ON... Ubiquitin-related tumor suppressors. FEBS Lett, 586, 1389. https://doi.org/10.1016/j.febslet.2012.04.006
  12. Kiessling AA, Bletsa R, Desmarais B, et al (2009). Evidence that human blastomere cleavage is under unique cell cycle control. J Assist Reprod Genet, 26, 187-95. https://doi.org/10.1007/s10815-009-9306-x
  13. Knuutila S, Aalto Y, Autio K, et al (1999). DNA copy number losses in human neoplasms. Am J Pathol, 155, 683-94. https://doi.org/10.1016/S0002-9440(10)65166-8
  14. Kocarnik JD, Hutter CM, Slattery ML, et al (2010) Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and meta-analysis. Cancer Epidemiol Biomarkers Prev, 19, 3131-9. https://doi.org/10.1158/1055-9965.EPI-10-0878
  15. Kotliarov Y, Steed ME, Christopher N, et al (2006). High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. Cancer Res, 66, 9428-36. https://doi.org/10.1158/0008-5472.CAN-06-1691
  16. Lee J, Kotliarova S, Kotliarov Y, et al (2006). Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell, 9, 391-403. https://doi.org/10.1016/j.ccr.2006.03.030
  17. Li Y, Mori T, Hata H, et al (2004). NIRF induces G1 arrest and associates with Cdk2. Biochem Biophys Res Commun, 319, 464-8. https://doi.org/10.1016/j.bbrc.2004.04.190
  18. Louis DN, Ohgaki H, Wiestler OD, et al (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol, 114, 97-109. https://doi.org/10.1007/s00401-007-0243-4
  19. Malumbres M, Barbacid M (2009). Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer, 9, 153-66. https://doi.org/10.1038/nrc2602
  20. Mori T, Ikeda DD, Fukushima T, et al (2011). NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor. Cell Cycle, 10, 3284-99. https://doi.org/10.4161/cc.10.19.17176
  21. Mori T, Ikeda DD, Yamaguchi Y, et al (2012). NIRF/UHRF2 occupies a central position in the cell cycle network and allows coupling with the epigenetic landscape. FEBS Lett, 586, 1570-83. https://doi.org/10.1016/j.febslet.2012.04.038
  22. Mori T, Li Y, Hata H, et al (2002). NIRF, a novel RING finger protein, is involved in cell-cycle regulation. Biochem Biophys Res Commun, 296, 530-6. https://doi.org/10.1016/S0006-291X(02)00890-2
  23. Mori T, Li Y, Hata H, et al (2004). NIRF is a ubiquitin ligase that is capable of ubiquitinating PCNP, a PEST-containing nuclear protein. FEBS Lett, 557, 209-14. https://doi.org/10.1016/S0014-5793(03)01495-9
  24. Nakayama KI , Nakayama K (2006). Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer, 6, 369-81. https://doi.org/10.1038/nrc1881
  25. Network CGAR (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455, 1061-8. https://doi.org/10.1038/nature07385
  26. Oliver L, Olivier C, Marhuenda FB, et al (2009). Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy. Curr Mol Pharmacol, 2, 263-84.
  27. Parry L, Clarke AR (2011). The Roles of the Methyl-CpG Binding Proteins in Cancer. Genes Cancer, 2, 618-30. https://doi.org/10.1177/1947601911418499
  28. Pichler G, Wolf P, Schmidt CS, et al (2011). Cooperative DNA and histone binding by Uhrf2 links the two major repressive epigenetic pathways. J Cell Biochem, 112, 2585-93. https://doi.org/10.1002/jcb.23185
  29. Qian G, Jin F, Chang L, et al (2012). NIRF, a novel ubiquitin ligase, interacts with hepatitis B virus core protein and promotes its degradation. Biotechnol Lett, 34, 29-36. https://doi.org/10.1007/s10529-011-0751-0
  30. Ren J, Wen L, Gao X, et al (2009). DOG 1.0: illustrator of protein domain structures. Cell Res, 19, 271-3. https://doi.org/10.1038/cr.2009.6
  31. Ulrich TA, de Juan Pardo EM, Kumar S (2009). The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells. Cancer Res, 69, 4167-74.
  32. Wang F, Zhang P, Ma Y, et al (2012). NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA. Cancer Lett, 314, 223-31. https://doi.org/10.1016/j.canlet.2011.09.033
  33. Wen PY, Kesari S (2008). Malignant gliomas in adults. N Engl J Med, 359, 492-507. https://doi.org/10.1056/NEJMra0708126
  34. Wu J, Liu S, Liu G, et al (2012). Identification and functional analysis of 9p24 amplified genes in human breast cancer. Oncogene, 31, 333-41. https://doi.org/10.1038/onc.2011.227
  35. Zhang J, Gao Q, Li P, et al (2011) S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA methylation maintenance. Cell Res, 21, 1723-39. https://doi.org/10.1038/cr.2011.176

Cited by

  1. The role of ubiquitin-proteasome system in glioma survival and growth vol.31, pp.3, 2013, https://doi.org/10.3109/08977194.2013.799156
  2. MAGED4 Expression in Glioma and Upregulation in Glioma Cell Lines with 5-Aza-2'-Deoxycytidine Treatment vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3495
  3. Ubiquitin-like with PHD and ring finger domains 2 is a predictor of survival and a potential therapeutic target in colon cancer vol.31, pp.4, 2014, https://doi.org/10.3892/or.2014.3035
  4. Multidimensional Proteomics Reveals a Role of UHRF2 in the Regulation of Epithelial-Mesenchymal Transition (EMT) vol.15, pp.7, 2016, https://doi.org/10.1074/mcp.M115.057448
  5. UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular carcinoma cells vol.39, pp.1, 2017, https://doi.org/10.3892/ijmm.2016.2805